Article Details

Chinese biotech firm Ansun BioPharma secures $80m Series B financing

Retrieved on: 2019-10-14 12:41:15

Tags for this article:

Click the tags to see associated articles and topics

Chinese biotech firm Ansun BioPharma secures $80m Series B financing. View article details on hiswai:

Excerpt

<div>Existing investors Lilly Asia Ventures, <b>Matrix Partners</b> China, 3E Bioventures Capital also joined the round, according to a statement on venture ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo